Obesity, insulin resistance and isolated low high-density-lipoprotein cholesterol in Chinese subjects

G T Ko1, C S Cockram, J Woo

  • 1Department of Medicine, Alice Ho Miu Ling Nethersole Hospital, Tai Po, NT, Hong Kong. gtc_ko@hotmail.com

Insights

In Hong Kong Chinese, 4.8% have isolated low high-density-lipoprotein cholesterol (HDL-C), linked to obesity. High triglycerides alongside low HDL-C indicate an insulin-resistant state, a key cardiovascular risk factor.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Isolated low high-density-lipoprotein cholesterol (HDL-C) presents a similar coronary heart disease risk to hypercholesterolemia.
  • Understanding the prevalence and metabolic associations of isolated low HDL-C in diverse populations is crucial for cardiovascular risk assessment.

Purpose of the Study:

  • To determine the prevalence of isolated low HDL-C among Hong Kong Chinese.
  • To investigate the relationship between isolated low HDL-C, insulin resistance, and triglyceride levels in this population.

Main Methods:

  • A population-based survey of 1493 Hong Kong Chinese subjects was conducted.
  • Insulin resistance was quantified using the homeostasis model assessment (HOMA) method.
  • Subjects were categorized based on total cholesterol (TC), HDL-C, and triglyceride (TG) levels.

Main Results:

  • 4.8% of subjects exhibited isolated low HDL-C.
  • Isolated low HDL-C with high triglycerides was associated with increased obesity, higher glucose, insulin levels, and insulin resistance.
  • Even without high triglycerides, isolated low HDL-C was linked to obesity compared to controls.

Conclusions:

  • Isolated low HDL-C affects 4.8% of Hong Kong Chinese and is strongly associated with obesity.
  • The presence of high triglycerides in individuals with isolated low HDL-C signifies an insulin-resistant state.
  • These findings highlight the importance of assessing HDL-C and triglyceride levels in cardiovascular risk evaluation.
Abstract

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...